LAUREN FARBIAK: Open Payments
NPI 1003476698 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 89 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,502 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $269 |
| Collegium Pharmaceutical, Inc. | 17 | $262 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $233 |
| PROTEGA PHARMACEUTIALS INC | 6 | $140 |
| Saluda Medical Americas, Inc. | 5 | $122 |
| Azurity Pharmaceuticals, Inc. | 6 | $112 |
| SCILEX PHARMACEUTICALS INC. | 6 | $101 |
| Forte Bio-Pharma LLC | 4 | $86 |
| Boston Scientific Corporation | 1 | $52 |
| BIOTRONIK NRO, Inc. | 1 | $39 |
Products named: XTAMPZA, RELISTOR, UBRELVY, ROXYBOND, Evoke, QULIPTA, HORIZANT, PROLATE.
Industry payments across TX — which companies pay providers there.
